If you're sexually active and don't want to get pregnant right now, birth control is one of the most effective tools available. Understanding what your options are, and how to get access ...

A group of 53 biotech leaders is expressing support for mifepristone in a letter to the FDA, urging the agency not to impose new restrictions on its use as an abortion medication and slamming a ...

While it trails Johnson & Johnson’s Tecvayli, Regeneron still hopes Lynozyfic can differentiate in terms of dosing ...

Former Senate HELP ranker Richard Burr has pulled in yet another new lobbying client from the pharmaceuticals world.

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs for millions of people.